GeneCentric Therapeutics Identifies RNA-Based Genomic Markers of Clinical Response in Lung Cancer

DURHAM, N.C., Dec. 21, 2021 — GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, announced today the completion of its Piedmont Study, conducted in collaboration with Atrium Health Levine Cancer Institute.

Army Distaff Foundation honors Ret. Army Col. Deborah Birx, M.D. and Brian Caveney, M.D. with 2021 Dwight D. and Mamie Eisenhower Distinguished Citizen Awards

WASHINGTON, D.C. Dec. 13, 2021 – The Army Distaff Foundation (ADF) is honoring Dr. Deborah Birx and Dr. Brian Caveney for their professional, medical contributions to the U.S. public health and that of Knollwood Military Life Plan Community (Knollwood) during the COVID-19 pandemic. They will receive 2021 Dwight D. & Mamie Eisenhower Distinguished Citizen Awards at the 25th Annual ADF Gala on December 11, 2021. 

Labcorp announces initiatives to enhance shareholder value

BURLINGTON, N.C. --(BUSINESS WIRE)--Dec. 9, 2021-- Labcorp (NYSE: LH) (the Company), a leading global life sciences company, today announced actions that its Board of Directors (the Board) and management team have taken to enhance shareholder returns. 

Labcorp completes acquisition of Toxikon corporation

BURLINGTON, N.C. --(BUSINESS WIRE)--Dec. 3, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has closed its acquisition of Toxikon Corporation , a contract research organization delivering best-in-class nonclinical testing services.

Labcorp and ConcertAI optimize precision oncology research with real-world data and artificial intelligence

BURLINGTON, N.C. & CAMBRIDGE, Mass. --(BUSINESS WIRE)--Dec. 1, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, and ConcertAI, LLC (ConcertAI), a leader in enterprise artificial intelligence (AI) and real-world data (RWD) solutions for life science companies and health care providers, today announced a collaboration to optimize precision oncology research. The companies will work together to launch clinical studies in ways that minimize the burden on physician practices, drive faster patient recruitment, maximize patient retention and ensure equitable access to research as a care option.